These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8590441)

  • 1. Antitumor effects of pirarubicin and epirubicin in combination with doxifluridine and cisplatin against mouse P388 leukemia.
    Agata N; Mase T; Izumi H; Hirano S; Iguchi H; Tone H; Takeuchi T
    Cancer Biochem Biophys; 1995 Nov; 15(2):95-101. PubMed ID: 8590441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
    Izumi H; Hirano S; Matsushita Y; Iguchi H; Tone H; Takeuchi T
    Cancer Biochem Biophys; 1994 Sep; 14(2):137-49. PubMed ID: 7889494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of antitumor activity of pirarubicin by chlorpromazine in mice bearing doxorubicin-resistant P388 leukemia.
    Shibata H; Maekawa I; Furusawa S; Kawauchi H; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):359-62. PubMed ID: 2093213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined effect of CDDP with various types of antitumor drugs against P 388 leukemia].
    Uchida T; Nishikawa K; Shibasaki C; Okamoto K; Arakawa M; Ekimoto H; Takahashi K
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2275-82. PubMed ID: 2735770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination therapy of doxifluridine, pirarubicin and cisplatin for human gastric cancers implanted in nude mice].
    Inaba M; Sato S; Yoshimura M; Ohnishi Y; Yamori T; Tashiro T
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1793-8. PubMed ID: 7574812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T; Oh-Hara T; Sudo Y; Naito M
    Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
    Akamatsu K; Endo K; Tsunenari T; Matsumoto T; Kaiho S; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):229-35. PubMed ID: 1736835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of advanced gastric cancer successfully treated with combination chemotherapy using THP, 5'-DFUR and CDDP, followed by surgical resection].
    Murakami H; Adachi H; Kurihara T; Tamura Y; Kobori O; Saito K; Kurihara M
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1111-4. PubMed ID: 7611764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
    Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM; Kabieva AO
    Biull Eksp Biol Med; 1990 Mar; 109(3):290-2. PubMed ID: 2364157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines].
    Nagasawa M; Ishii S; Kariya Y; Itoh O; Yamamoto H; Kawaharajo K; Takeuchi T
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):633-8. PubMed ID: 2108612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
    Uchida T; Nagahata T; Arakawa M; Ekimoto H; Takahashi K
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1351-6. PubMed ID: 2114829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC; Sidky YA; Hatcher JF; Bryan GT
    Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synergism of sobuzoxane in combination with doxorubicin against leukemia P388 in mice].
    Dai ZQ; Xu JY; Yuan XJ; Cai JC
    Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):69-71. PubMed ID: 8737460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors].
    Miwa M; Eda H; Fukuda H; Fujimoto K; Ishitsuka H
    Gan To Kagaku Ryoho; 1988 May; 15(5):1755-63. PubMed ID: 2967051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fundamental study of combination chemotherapy with THP, 5-FU and CDDP for human KB carcinoma cell line and its multidrug resistant cell line KB-C1--usefulness of treatment with 5-FU preceding CDDP].
    Kishimoto H; Manno Y; Tanaka H; Moridera K; Urade M
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):505-9. PubMed ID: 11329785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination chemotherapy with 3 or 4 drugs on human breast and gastrointestinal cancer xenografts in nude mice (II)].
    Fujita F; Fujita M; Sakamoto Y; Shimozuma K; Inaba H; Taguchi T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1252-9. PubMed ID: 2953310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation by vitamin A of the action of anticancer agents against murine tumors.
    Nakagawa M; Yamaguchi T; Ueda H; Shiraishi N; Komiyama S; Akiyama S; Ogata J; Kuwano M
    Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
    Li LH; DeKoning TF; Wallace TL
    Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
    Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
    Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.